Synthaverse S.A. (WSE:SVE)
2.865
+0.005 (0.17%)
Jul 3, 2026, 5:00 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 217.08 million as of July 2, 2026. Its market cap has decreased by -39.14% in one year.
Market Cap
217.08M
Enterprise Value
299.41M
Revenue
42.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.87
Market Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 217.08M, an increase of 50.75%. That is a compound annual growth rate of 2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 217.08M | -15.96% |
| Dec 30, 2025 | 258.31M | -18.67% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioceltix | 496.24M |
| Captor Therapeutics Spolka Akcyjna | 475.23M |
| Syn2bio | 427.90M |
| Ryvu Therapeutics | 353.74M |
| BIOTON | 340.88M |
| Molecure | 124.44M |
| Mabion | 117.66M |
| Poltreg | 110.93M |